Evidence map›Paper›PMID 41347105›Full record

ArticleReumatologia2025

Clinical features and chronology of clinical manifestations in Behçet's disease: a cohort of 2,615 patients.

Shokufe Sadeghi, Seyedeh Tahereh Faezi, Mohammad Nejadhosseinian, Hoda Haerian, Azarakhsh Baghdadi, Farhad Shahram, Massoomeh Akhlaghi, Majid Alikhani, Gilava Hedayati Emam, Fereydoun Davatchi

Abstract read
In one paragraph

Article in Reumatologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shokufe SadeghiRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0009-0001-3506-822X
Seyedeh Tahereh FaeziRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0002-5828-7556
Mohammad NejadhosseinianRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0002-7977-5129
Hoda HaerianRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0002-0347-0337
Azarakhsh BaghdadiRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0003-0783-9207
Farhad ShahramRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0003-1830-6203
Massoomeh AkhlaghiRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0001-6200-5040
Majid AlikhaniRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0001-6200-5040
Gilava Hedayati EmamRheumatology Research Center, Tehran University of Medical Sciences, Iran.
Fereydoun DavatchiRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0003-0508-7013

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Behçet's disease (BD) presents with highly variable clinical manifestations and a heterogeneous pattern of symptom development. This study aimed to assess the chronology of symptom onset and clinical findings in BD patients at a nationally recognized Behçet's referral center and to examine associations between symptom progression and patient- and disease-related characteristics. Material and methods: A retrospective review of BD patients from a national referral center in Iran was conducted between March 2007 and March 2017. Patients with ≥ 2 years of follow-up were included. Demographic data, clinical characteristics, and laboratory findings were extracted. The initial symptom and the sequence of symptom development were analyzed. The time between symptom onset and diagnosis was recorded, and comparisons were made based on sex, age, human leukocyte antigen (HLA) type, and initial presenting symptom. Results: A total of 2,615 patients (58.7% male) were included. The mean age at BD diagnosis was 25.0 ±10.1 years, with a median follow-up of 26 years. Oral ulcers were the most common manifestation (98.9% overall) and the most frequent initial symptom (90.3%). Genital ulcers were observed in 61.3% of patients, with a mean onset 4.6 ±5.7 years after diagnosis. Ocular and vascular manifestations had the longest latency from diagnosis. Male patients had a shorter time to onset of oral ulcers ( Conclusions: Our findings highlight substantial temporal heterogeneity in BD symptom progression. While oral ulcers appear early, genital ulcers and skin manifestations tend to develop later, and ocular and vascular lesions exhibit the longest delay. The chronology of symptom onset is significantly influenced by age, sex, HLA-B5/B51 status, and initial presenting symptom. These findings underscore the importance of long-term follow-up in BD management.

Indexed as

Behçet’s diseasechronologygenital ulcersoral ulcers

Identifiers

PMID41347105
PMCPMC12673816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.